Primary placement of a titanium sleeve in hydroxyapatite orbital implants

Eye

Volumn 19, Issue 4, 2005, Pages 400-405

  Liao, S L ^a   Chen, M S ^a   Lin, L L K ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Enucleation; Evisceration; Hydroxyapatite implant; Titanium sleeve

Indexed keywords

HYDROXYAPATITE; TITANIUM;

ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA SURGERY; ENDOPROSTHESIS LOOSENING; ENUCLEATION; EYE SURGERY; FOLLOW UP; HUMAN; IMAGE ANALYSIS; ORBIT IMPLANT; POSTOPERATIVE INFECTION; REHABILITATION; SURGICAL TECHNIQUE; TENSION;

EID: 17544364877     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701509     Document Type: Article

References (18)

1. Perry AC. Integrated orbital implants. Adv Ophthalmic Plast Reconstr Surg 1990; 8: 75-81.
2. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991; 98: 370-377.
3. Jordan DR, Gilberg S, Mawn L, Brownstein S, Grahovac SZ. The synthetic hydroxyapatite implant: a report on 65 patients. Ophthal Plast Reconstr Surg 1998; 14: 250-255.
4. Hornblass A, Biesman BS, Eviatar JA. Current techniques of enucleation: a survey of 5,439 intraorbital implants and a review of the literature. Ophthal Plast Reconstr Surg 1995; 11: 77-88.
5. Jordan DR. Anophthalmic orbital implants. Ophthalmol Clin North Am 2000; 13: 587-608.
6. Remulla HD, Rubin PAD, Shore JW, Sutula FC, Townsend DJ, Woog JJ et al. Complications of porous spherical orbital implants. Ophthalmology 1995; 102: 586-593.
7. Jordan DR, Chan S, Mawn L, Gilberg S, Dean T, Brownstein S et al. Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology 1999; 106: 505-512.
8. Hsu WC, Green JP, Spilker MH, Rubin PA. Primary placement of a titanium motility post in a porous orbital implant: animal model with quantitative assessment of fibrovascular ingrowths and vascular density. Ophthal Plast Reconstr Surg. 2000; 16: 370-379.
9. Rubin PAD, Fay AM, Remulla HD. Primary placement of a motility coupling post in porous polyethylene orbital implants. Arch Ophthalmol 2000; 118: 826-832.
10. Shields CL, Shields JA, De Potter P, Singh AD. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol 1994; 78: 702-706.
11. De Potter P, Shields CL, Shields JA, Singh AD. Use of the hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol 1994; 112: 208-212.
12. Massy GG, Holds JB. Coralline hydroxyapatite spheres secondary orbital implants in anophthalmos. Ophthalmology 1995; 102: 161-166.
13. Shields CL, Shields JA, De Potter P. Hydroxyapatite orbital implant after enucleation: experience with initial 100 consecutive cases. Arch Ophthalmol 1992; 110: 333-338.
14. Shields CL, Shields JA, Eagle Jr RC, De Potter P. Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant. Am J Ophthalmol 1991; 111: 363-366.
15. Baumgarten D, Wojno T, Taylor Jr A. Evaluation of biomatrix hydroxyapatite ocular implants with technetium-99m-MDP. J Nucl Med 1993; 34: 467-468.
16. De Potter P, Shields C, Shields J, Flanders AE, Rao VM. Role of magnetic resonance imaging in the evaluation of the hydroxyapatite orbital implant. Ophthalmology 1992; 99: 824-830.
17. Edelstein C, Shields CL, De Potter P, Shields JA. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology 1997; 104: 1616-1621.
18. Chun-Ju Lin, Shu-Lang Liao, Jieh-Ren Jou, Kao SC, Hou PK, Chen MS. Complications of motility peg placement for porous hydroxyapatite orbital implants. Br J Ophthalmol. 2002; 86: 394-396.